Giulia Nicolaio
Research Subjects
Giulia Nicolaio has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Perone
Cardiac Rehabilitation Unit, Rehabilitation Clinic “Villa delle Magnolie”, 81020 Castel Morrone, Italy
2 shared publications - Alessandra Pratesi
Department of Experimental and Clinical Medicine, University of Florence, Italy
1 shared publication - Andrea Ungar
Division of Geriatric and Cardiogeriatric Medicine, Department of Experimental and Clinical Medicine, University of Florence, Careggi University Hospital, Florence, Italy
1 shared publication - Anna Maria Martone
Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, 00168 Rome, Italy
1 shared publication - Chiara Ceolin
Department of Medicine (DIMED), University of Padova, Padova, Italy
1 shared publication - Costanza Burgisser
Department of Experimental and Clinical Medicine, University of Florence, Italy
1 shared publication
Latest Publications
- Open Access
- 23 May 2026
- Published by MDPI AG in Journal of Gerontology and Geriatrics
- Vol. 74 (2) , 14
Heart Failure and Sarcopenia: An Integrated Rehabilitation Approach Combining Exercise and Nutrition
Sarcopenia, characterized by progressive loss of muscle mass and function, is highly prevalent among patients with heart failure (HF) and contributes to frailty, disability, and poor prognosis. Shared mechanisms—chronic inflammation, neurohormonal dysregulation, mitochondrial dysfunction, inactivity, and inadequate nutrition—promote anabolic resistance and accelerate muscle wasting. This narrative review summarizes current evidence on the interplay between HF and sarcopenia, focusing on practical strategies for integrated management. Exercise training, particularly combined aerobic and resistance programs, improves physical performance and quality of life, while targeted nutritional interventions ensure adequate energy and protein intake and mitigate malnutrition. Emerging evidence supports the synergistic benefit of coupling tailored dietary support with structured rehabilitation. Despite robust data, implementation of person-centered, multidisciplinary care remains limited. Routine screening for sarcopenia and nutritional risk should be embedded in HF pathways to enable early intervention, functional recovery, and improved long-term outcomes.
- 23 May 2026
- Published by MDPI AG in Journal of Gerontology and Geriatrics
- Vol. 74 (2) , 14
Open AccessHeart Failure and Sarcopenia: An Integrated Rehabilitation Approach Combining Exercise and Nutrition
Sarcopenia, characterized by progressive loss of muscle mass and function, is highly prevalent among patients with heart failure (HF) and contributes to frailty, disability, and poor prognosis. Shared mechanisms—chronic inflammation, neurohormonal dysregulation, mitochondrial dysfunction, inactivity, and inadequate nutrition—promote anabolic resistance and accelerate muscle wasting. This narrative review summarizes current evidence on the interplay between HF and sarcopenia, focusing on practical strategies for integrated management. Exercise training, particularly combined aerobic and resistance programs, improves physical performance and quality of life, while targeted nutritional interventions ensure adequate energy and protein intake and mitigate malnutrition. Emerging evidence supports the synergistic benefit of coupling tailored dietary support with structured rehabilitation. Despite robust data, implementation of person-centered, multidisciplinary care remains limited. Routine screening for sarcopenia and nutritional risk should be embedded in HF pathways to enable early intervention, functional recovery, and improved long-term outcomes.
- Open Access
- 30 April 2024
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 21, 200273
Gender difference in long-term effect of cardiac rehabilitation; data from CRAGE-extra study
- 30 April 2024
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 21, 200273
Open AccessGender difference in long-term effect of cardiac rehabilitation; data from CRAGE-extra study
- Open Access
- 11 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (16) , 5233
Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence
Coronary artery disease (CAD) is highly prevalent in older adults, yet its management remains challenging. Treatment choices are made complex by the frailty burden of older patients, a high prevalence of comorbidities and body composition abnormalities (e.g., sarcopenia), the complexity of coronary anatomy, and the frequent presence of multivessel disease, as well as the coexistence of major ischemic and bleeding risk factors. Recent randomized clinical trials and epidemiological studies have provided new data on optimal management of complex patients with CAD. However, frail older adults are still underrepresented in the literature. This narrative review aims to highlight the importance of assessing frailty as an aid to guide therapeutic decision-making and tailor CAD management to the specific needs of older adults, taking into account age-related pharmacokinetic and pharmacodynamic changes, polypharmacy, and potential drug interactions. We also discuss gaps in the evidence and offer perspectives on how best in the future to optimize the global strategy of CAD management in older adults.
- 11 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (16) , 5233
Open AccessManagement of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence
Coronary artery disease (CAD) is highly prevalent in older adults, yet its management remains challenging. Treatment choices are made complex by the frailty burden of older patients, a high prevalence of comorbidities and body composition abnormalities (e.g., sarcopenia), the complexity of coronary anatomy, and the frequent presence of multivessel disease, as well as the coexistence of major ischemic and bleeding risk factors. Recent randomized clinical trials and epidemiological studies have provided new data on optimal management of complex patients with CAD. However, frail older adults are still underrepresented in the literature. This narrative review aims to highlight the importance of assessing frailty as an aid to guide therapeutic decision-making and tailor CAD management to the specific needs of older adults, taking into account age-related pharmacokinetic and pharmacodynamic changes, polypharmacy, and potential drug interactions. We also discuss gaps in the evidence and offer perspectives on how best in the future to optimize the global strategy of CAD management in older adults.